Author: OurCrowd

[Airobotics in PR Newswire] Airobotics is proceeding towards Type Certification of its automated drone system after final airworthiness criteria was published by the FAA

PETAH TIKVA, Israel, March 30, 2022 /PRNewswire/ — AIROBOTICS (TASE: AIRO) An Israeli manufacturer of autonomous Unmanned Aircraft (drones) and Aerial Data Platforms is heading towards completion of a type certification process after the Federal Aviation Administration (FAA) published the final airworthiness criteria for certification of its automated drone system marking an important milestone on its way to complete the first of its kind regulatory process of type certification in the USA. Read...

Read More

[Aria Pharmaceuticals in Drug Target Review] An equal seat at the table for AI in pharmaceutical discovery

This article explores the current state of artificial intelligence (AI) in drug discovery and development, discussing the obstacles holding back wider adoption. Dr Mark Eller, Senior Vice President of Research and Development at Aria Pharmaceuticals, makes the case that to succeed, AI must be integrated as a partner alongside core pharmaceutical R&D disciplines. Read...

Read More